NIPH Clinical Trials Search

Effects of indigestible dextrin on postprandial glucose level ,lipid value and incretin secretion in healty subjects and type 2 diabetic patients

Basic Information

Recruitment status	Recruiting
Health condition(s) or Problem(s) studied	Diabetes
Date of first enrollment	2009/12/01
Target sample size	20
Countries of recruitment	Japan
Study type	Interventional
Intervention(s)	No administration of indigestible dextrin Administration of indigestible dextrin once Administration of indigestible dextrin for seven days

Outcome(s)

Primary Outcome	postprandial incretin secretion
Secondary Outcome	1.postprandial glucose level 2.postprandial lipid level 3.postprandial insulin secretion

Key inclusion & exclusion criteria

Age minimum	18years-old
Age maximum	80years-old
Gender	Male and Female
Include criteria
Exclude criteria	1.Patients who are receiving insulin therapy. 2.Patients who have a severe hepatic dysfunction. 3.Patients who have a severe renal dysfunction.